Who backs Tubulis?
26 investors| Investor | Type |
|---|---|
| Fidelity Management & Research Company | Asset manager |
| High-Tech Gründerfonds | Venture capital |
| Blackstone | — |
| Bayern Kapital | Venture capital |
| Venrock | Venture capital |
| Wellington Management | Asset manager |
| EQT Life Sciences | Venture capital |
| Frazier Healthcare Partners | Venture capital |
| Andera Partners | PE / buyout |
| Deep Track Capital | Venture capital |
| + 16 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Tubulis investors
26 investors are on record for Tubulis, including Fidelity Management & Research Company, High-Tech Gründerfonds, Blackstone and Bayern Kapital. By type, the record holds 7 venture capital firms, 2 asset managers and 1 private equity firm. The Series C in Oct 2025 drew 15 investors.
Free account
More of Tubulis with a free account
- ·The complete investor list: 26 names
- ·Everyone on the team, board and advisors included
- ·Watch Tubulis: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 26 firms already write checks for companies like Tubulis in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View